Molecular epidemiology of the hepatitis C virus in Western Siberia
- PMID: 16173011
- DOI: 10.1002/jmv.20467
Molecular epidemiology of the hepatitis C virus in Western Siberia
Abstract
Western Siberia is the region with little information on the prevalence of hepatitis C virus (HCV) infection, genotypic diversity of HCV isolates and risk factors. A molecular epidemiological survey was conducted to clarify these issues. Four groups of volunteers were included in a cross-sectional study (n = 500 in each group): health care workers; daycare patients from a hospital for drug users, daycare patients from an AIDS prevention and control center; and persons admitted to a local general practice clinic for any reason (outpatients). The anti-HCV IgG prevalence was 4.6% in health care workers, 48.0% in a narcological center, 35.8% in AIDS center, and 5.6% in outpatients. HCV RNA was found in 79.3%-86.3% of seropositives. A total of 388 HCV isolates were genotyped by direct sequencing and phylogenetic analysis of the 5'-UTR and NS5B regions of HCV genome. The genotypes distribution was: 1b--50.3%, 2a--4.4%, 2c--0.3%, 3a--44.8%. One isolate (0.3%) could not be typed unambiguously. This genotypic diversity is intermediate between that of European Russia and China. Genotype 1 prevailed in an older age group (75% among 51-60 years old), and genotype 3 was most prevalent in young people (51.4% in 16-20 years old). A statistically significant (P < 0.05) increase in risk was found in intravenous drug users (odds ratio (OR) = 77.5), unemployed persons (OR = 16.3), persons having >4 sexual partners during lifetime (OR = 4.3), and male homosexuals (OR = 6.6).
(c) 2005 Wiley-Liss, inc.
Similar articles
-
Hepatitis C virus molecular epidemiology in Uzbekistan.J Med Virol. 2003 Mar;69(3):367-75. doi: 10.1002/jmv.10298. J Med Virol. 2003. PMID: 12526047
-
Changing prevalence of hepatitis C virus genotypes: molecular epidemiology and clinical implications in the hepatitis C virus hyperendemic areas and a tertiary referral center in Taiwan.J Med Virol. 2001 Sep;65(1):58-65. J Med Virol. 2001. PMID: 11505444
-
Contrasting patterns of hepatitis C virus infection in two regions from Tunisia.J Med Virol. 2005 Jun;76(2):185-93. doi: 10.1002/jmv.20342. J Med Virol. 2005. PMID: 15834884
-
Epidemiology of hepatitis C virus infection.Minerva Gastroenterol Dietol. 2005 Mar;51(1):15-29. Minerva Gastroenterol Dietol. 2005. PMID: 15756151 Review. English, Italian.
-
Hepatitis C virus infection in the Maghreb region.J Med Virol. 2013 Sep;85(9):1542-9. doi: 10.1002/jmv.23643. Epub 2013 Jun 18. J Med Virol. 2013. PMID: 23780703 Review.
Cited by
-
Hepatitis C virus infection among drug injectors in St Petersburg, Russia: social and molecular epidemiology of an endemic infection.Addiction. 2009 Nov;104(11):1881-90. doi: 10.1111/j.1360-0443.2009.02687.x. Epub 2009 Aug 27. Addiction. 2009. PMID: 19712125 Free PMC article.
-
Risk factors for infection with different hepatitis C virus genotypes in southern Brazil.ScientificWorldJournal. 2012;2012:946954. doi: 10.1100/2012/946954. Epub 2012 May 22. ScientificWorldJournal. 2012. PMID: 22666173 Free PMC article.
-
Introduction to molecular virology.Russ J Genet Appl Res. 2014;4(4):325-339. doi: 10.1134/S2079059714040078. Epub 2014 Aug 12. Russ J Genet Appl Res. 2014. PMID: 32226637 Free PMC article. No abstract available.
-
Frequency of Interferon-Resistance Conferring Substitutions in Amino Acid Positions 70 and 91 of Core Protein of the Russian HCV 1b Isolates Analyzed in the T-Cell Epitopic Context.J Immunol Res. 2018 Feb 7;2018:7685371. doi: 10.1155/2018/7685371. eCollection 2018. J Immunol Res. 2018. PMID: 29577052 Free PMC article.
-
Survival of hepatitis C virus in syringes: implication for transmission among injection drug users.J Infect Dis. 2010 Oct 1;202(7):984-90. doi: 10.1086/656212. J Infect Dis. 2010. PMID: 20726768 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical